We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Simultaneously Operated Preclinical PET/MRI Imaging Research Scanners Available

By HospiMedica International staff writers
Posted on 28 Oct 2015
For the first time researchers now have access to preclinical imaging systems for simultaneous Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) imaging.

Simultaneous acquisition of PET and MRI images provides researchers with more accurate comparative results, saves time, reduces radiation exposure, and can benefit neurobiology, cardiovascular, and cancer research scientists. More...
A combined system enables researchers to view dynamic physiological and pathological processes, and locate PET findings more accurately as a result of improved image registration, and image fusion.

The combined PET/MRI system was developed by MR Solutions (Guildford, Surrey, UK), a global MRI imaging leader with more than 1,000 installations globally in the last 30 years. The new MRS-PET system is inserted in the cryogen-free 3-T, 4.7-T, or 7-T MRI magnet and has an imaging resolution of <0.8 mm.

MR Solutions also offers a lower cost solution, a sequential PET/MR imaging system, made by clipping MRS-PET in front of the bore of the MRI technology. This solution enables automatic imaging from one modality to another on the same axis, and allows MRI or PET imaging to be used independently without the need to move research subjects to a different machine.

Chief Executive, MR Solutions, Dr. David Taylor, said, “We are always looking at ways to improve research results. Our multimodality technology now facilitates simultaneous PET/MRI imaging for much faster research outcomes as well as the acquisition of data from two imaging modalities simultaneously. Researchers will be able to quickly carry out their work on subjects with rapidly changing physiological and pathological processes. A great deal of time can now be saved in the laboratory helping to speed up drug development.”

Related Links:

MR Solutions



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Silver Member
ECG Management System
NEMS Web
Blood Bank Refrigerator
MBR-705GR-PE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.